4//SEC Filing
Mehra Uneek 4
Accession 0000950170-25-111986
CIK 0001869105other
Filed
Aug 27, 8:00 PM ET
Accepted
Aug 28, 4:34 PM ET
Size
5.5 KB
Accession
0000950170-25-111986
Insider Transaction Report
Form 4
Mehra Uneek
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-08-26+633,570→ 633,570 totalExercise: $9.59Exp: 2035-08-25→ Common Stock (633,570 underlying)
Footnotes (1)
- [F1]25% of the shares underlying such option shall vest on July 21, 2026, with the remainder vesting in thirty-six substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service the Issuer on each such vesting date.
Documents
Issuer
BridgeBio Oncology Therapeutics, Inc.
CIK 0001869105
Entity typeother
Related Parties
1- filerCIK 0001881504
Filing Metadata
- Form type
- 4
- Filed
- Aug 27, 8:00 PM ET
- Accepted
- Aug 28, 4:34 PM ET
- Size
- 5.5 KB